Januvia

Januvia Indications/Uses

sitagliptin

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Monotherapy: As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
Combination with Metformin: In patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin as initial therapy or when the single agent alone, with diet and exercise, does not provide adequate glycemic control. Initial combination therapy or maintenance of combination therapy may not be appropriate for all patients. These management options are left to the discretion of the health care provider.
Combination with a Sulfonylurea: In patients with type 2 diabetes mellitus to improve glycemic control in combination with a sulfonylurea when treatment with maximal tolerated dose of sulfonylurea alone, with diet and exercise, does not provide adequate glycemic control and when metformin is inappropriate due to contraindications or intolerance.
Combination with Metformin and a Sulfonylurea: In patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin and a sulfonylurea when dual therapy with these 2 agents and with diet and exercise does not provide adequate glycemic control.
Combination with a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist: In patients with type 2 diabetes mellitus to improve glycemic control in combination with a PPARγ agonist (eg, thiazolidinediones) when diet and exercise, plus the single agent do not provide adequate glycemic control.
Combination with Metformin and a PPARγ Agonist: In patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin and a PPARγ agonist (eg, thiazolidinediones) when dual therapy with these agents, with diet and exercise does not provide adequate glycemic control.
Combination with Insulin: In patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in combination with insulin (with or without metformin).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in